Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine
Vaccines, 2023 Background: The variation in the reported vaccine safety and effectiveness could contribute to the high rates of vaccine hesitancy among the general population and healthcare workers in areas where monkeypox (mpox) is circulating.
Ramy Mohamed Ghazy +17 more
doaj +1 more source
Randomized, Controlled Trial of the Long Term Safety, Immunogenicity and Efficacy of RTS,S/AS02(D) Malaria Vaccine in Infants Living in a Malaria-Endemic Region. [PDF]
, 2013 The RTS,S/AS malaria candidate vaccine is being developed with the intent to be delivered, if approved, through the Expanded Programme on Immunization (EPI) of the World Health Organization.
A Olotu +43 more
core +5 more sources
Anticipated HIV Vaccine Acceptability among Sexually Active African-American Adult Women
Vaccines, 2013 An HIV vaccine, once it becomes available, could reduce vulnerability to HIV among African-American women. The purpose of this study was to assess determinants of HIV vaccine acceptability among African-American women across hypothetical levels of ...
Mark Mulligan +6 more
doaj +1 more source
Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia [PDF]
, 2018 Background: A number of Zika vaccine platforms are currently being investigated, some of which have entered clinical trials. We sought to evaluate the cost-effectiveness of a potential Zika vaccine candidate under the WHO Vaccine Target Product Profile ...
Moghadas, Seyed +2 more
core +2 more sources
Journal of Epidemiology, 2016 Background: While the immunogenicity and effectiveness of seasonal influenza vaccines among subjects with severe motor and intellectual disability (SMID) are known to be diminished, the efficacy of the A/H1N1pdm vaccine has not been evaluated.
Megumi Hara
doaj +1 more source
Vaccines, 2023 The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthetic peptide ...
Alexander B. Ryzhikov +26 more
doaj +1 more source
An Sveir Model for Assessing Potential Impact of an Imperfect Anti-SARS Vaccine [PDF]
, 2006 The control of severe acute respiratory syndrome (SARS), a fatal contagious viral disease that spread to over 32 countries in 2003, was based on quarantine of latently infected individuals and isolation of individuals with clinical symptoms of SARS ...
Gumel, Abba B. +2 more
core +2 more sources
Approximating instantaneous vaccine efficacy from cumulative vaccine efficacy [PDF]
, 2018 AbstractFew methods exist to estimate vaccine efficacy and its decay following immunisation. Existing methods are largely based on survival analyses such as Poisson or Cox-regression, applied to individual-level data from randomised placebo-controlled trials (RCTs), however, such are often not easily available for analysing pooling evidence across ...
Zandvoort, Kevin van +3 more
openaire +1 more source
Understanding COVID-19 vaccine efficacy [PDF]
Science, 2020 Vaccine efficacy in high-risk groups and reduced viral shedding are important for ...
Lipsitch, Marc, Dean, Natalie E.
openaire +2 more sources
An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting. [PDF]
, 2005 BACKGROUND: Polysaccharide pneumococcal vaccination for older adults is being introduced in developed country settings. Evidence of protection by this vaccine against pneumococcal pneumonia, or confirmation that illness and death from bacteraemia are ...
Cutts, Felicity T +3 more
core +1 more source